Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vivitrol and Employment-Based Reinforcement for Opioid Dependence
NCT01556425Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- May 2012
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of naltrexone in opioid use disorder (OUD) (4 arms), sponsored by Johns Hopkins University. Primary endpoint: Percent of Weekly Urine Samples Negative for Opiates at 24 weeks. Started May 2012; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01556425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01556425.